Michael Brooks's most recent trade in Edesa Biotech Inc was a trade of 207,201 Common Shares done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edesa Biotech Inc | Michael Brooks | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 207,201 | 224,870 (2%) | 2% | 0 | Common Shares | |
| LKQ | Michael T. Brooks | SVP -- CIO | 01 Mar 2024 | 1,472 | 30,638 (0%) | 0% | 52.0 | 76,523 | Common Stock | |
| LKQ | Michael T. Brooks | SVP -- CIO | 22 Feb 2024 | 5,953 | 32,110 (0%) | 0% | 0 | Common Stock | ||
| LKQ | T. Brooks Michael | SVP -- CIO | 22 Feb 2024 | 4,942 | 28,819 (0%) | 0% | 0 | Common Stock | ||
| LKQ | T. Michael Brooks | SVP -- CIO | 22 Feb 2024 | 2,662 | 26,157 (0%) | 0% | 51.8 | 137,883 | Common Stock | |
| LKQ | T. Brooks Michael | SVP -- CIO | 16 Jan 2024 | 227 | 23,877 (0%) | 0% | 47.1 | 10,698 | Common Stock | |
| LKQ | Michael T. Brooks | SVP -- CIO | 01 Sep 2023 | 1,000 | 24,104 (0%) | 0% | 52.8 | 52,824 | Common Stock | |
| Edesa Biotech Inc | Michael Brooks | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2023 | 80,000 | 80,000 | - | - | Share Option (right to buy) | |
| LKQ | Michael T. Brooks | SVP -- CIO | 14 Jul 2023 | 202 | 25,104 (0%) | 0% | 58.1 | 11,733 | Common Stock | |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.62 per share. | 16 May 2023 | 1,342 | 122,033 (0%) | 0% | 41.6 | 55,854 | Class A Common Stock |
| LKQ | Michael T. Brooks | SVP -- CIO | 01 Mar 2023 | 1,536 | 25,306 (0%) | 0% | 57.3 | 88,013 | Common Stock | |
| LKQ | Michael T. Brooks | SVP -- CIO | 23 Feb 2023 | 5,352 | 26,842 (0%) | 0% | 0 | Common Stock | ||
| LKQ | Michael T. Brooks | SVP -- CIO | 23 Feb 2023 | 4,157 | 23,845 (0%) | 0% | 0 | Common Stock | ||
| LKQ | Michael T. Brooks | SVP -- CIO | 23 Feb 2023 | 2,355 | 21,490 (0%) | 0% | 55.7 | 131,258 | Common Stock | |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 2,083 | 123,375 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 738 | 121,292 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.22 per share. | 16 Feb 2023 | 2,528 | 120,554 (0%) | 0% | 39.2 | 99,148 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 47,495 | 124,241 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.76 per share. | 17 Jan 2023 | 1,359 | 7,586 (0%) | 0% | 34.8 | 47,239 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.76 per share. | 17 Jan 2023 | 1,161 | 76,746 (0%) | 0% | 34.8 | 40,356 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.80 per share. | 17 Jan 2023 | 1,159 | 123,082 (0%) | 0% | 34.8 | 40,333 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.80 per share. | 17 Jan 2023 | 561 | 7,025 (0%) | 0% | 34.8 | 19,523 | Class A Common Stock |
| LKQ | Michael T. Brooks | SVP -- CIO | 17 Jan 2023 | 227 | 19,688 (0%) | 0% | 58 | 13,166 | Common Stock | |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 30,355 | 77,907 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.61 per share. | 15 Dec 2022 | 397 | 8,945 (0%) | 0% | 34.6 | 13,740 | Class A Common Stock |
| Edesa Biotech Inc | Michael Brooks | President | Grant, award, or other acquisition of securities at price $ 1.13 per share. | 02 Nov 2022 | 4,239 | 30,480 (0%) | 0% | 1.1 | 4,769 | Common Shares |
| Edesa Biotech Inc | Michael Brooks | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2022 | 2,119 | 2,119 | - | - | Common Share Warrants (Right to Buy) | |
| Edesa Biotech Inc | Michael Brooks | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2022 | 2,119 | 2,119 | - | - | Common Share Warrants (Right to Buy) | |
| LKQ | Michael T. Brooks | SVP -- CIO | 01 Sep 2022 | 1,082 | 19,915 (0%) | 0% | 53.1 | 57,402 | Common Stock | |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 78.00 per share. | 28 Jul 2022 | 1,002 | 47,552 (0%) | 0% | 78 | 78,156 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 78.00 per share. | 28 Jul 2022 | 500 | 9,342 (0%) | 0% | 78 | 39,000 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 76.00 per share. | 21 Jul 2022 | 1,002 | 48,554 (0%) | 0% | 76 | 76,152 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 76.00 per share. | 21 Jul 2022 | 500 | 9,842 (0%) | 0% | 76 | 38,000 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 74.00 per share. | 19 Jul 2022 | 1,002 | 49,556 (0%) | 0% | 74 | 74,148 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 74.00 per share. | 19 Jul 2022 | 500 | 10,342 (0%) | 0% | 74 | 37,000 | Class A Common Stock |
| LKQ | Michael T. Brooks | SVP -- CIO | 14 Jul 2022 | 202 | 20,997 (0%) | 0% | 49.4 | 9,980 | Common Stock | |
| Edesa Biotech Inc | Michael Brooks | President | Purchase of securities on an exchange or from another person at price $ 1.49 per share. | 29 Jun 2022 | 3,000 | 26,241 (0%) | 0% | 1.5 | 4,483 | Common Shares |
| Edesa Biotech Inc | Michael Brooks | President | Purchase of securities on an exchange or from another person at price $ 1.61 per share. | 16 Jun 2022 | 3,000 | 23,241 (0%) | 0% | 1.6 | 4,817 | Common Shares |
| Edesa Biotech Inc | Michael Brooks | President | Purchase of securities on an exchange or from another person at price $ 1.74 per share. | 25 May 2022 | 3,500 | 20,241 (0%) | 0% | 1.7 | 6,090 | Common Shares |
| Syneos Health Inc - Ordina... | Michael Brooks | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 13,781 | 50,558 (0%) | 0% | 0 | Class A Common Stock | |
| Edesa Biotech Inc | Michael Brooks | President | Purchase of securities on an exchange or from another person at price $ 2.79 per share. | 14 Mar 2022 | 1,250 | 16,741 (0%) | 0% | 2.8 | 3,487 | Common Shares |
| Edesa Biotech Inc | Michael Brooks | President | Purchase of securities on an exchange or from another person at price $ 3.22 per share. | 10 Mar 2022 | 1,000 | 15,491 (0%) | 0% | 3.2 | 3,223 | Common Shares |
| Edesa Biotech Inc | Michael Brooks | President | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 08 Mar 2022 | 1,250 | 14,491 (0%) | 0% | 2.9 | 3,622 | Common Shares |
| Syneos Health Inc - Ordina... | Michael Brooks | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 1,324 | 36,777 (0%) | 0% | 0 | Class A Common Stock | |
| LKQ | Michael T. Brooks | SVP -- CIO | 01 Mar 2022 | 1,083 | 21,199 (0%) | 0% | 46.2 | 50,037 | Common Stock | |
| Edesa Biotech Inc | Michael Brooks | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 43,500 | 43,500 | - | - | Stock Option (right to buy) | |
| LKQ | Michael T. Brooks | SVP -- CIO | 17 Feb 2022 | 6,133 | 22,282 (0%) | 0% | 0 | Common Stock | ||
| LKQ | Michael T. Brooks | SVP -- CIO | 17 Feb 2022 | 613 | 16,149 (0%) | 0% | 48.7 | 29,825 | Common Stock | |
| Syneos Health Inc - Ordina... | Michael Brooks | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.37 per share. | 16 Feb 2022 | 3,847 | 35,453 (0%) | 0% | 83.4 | 320,724 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Michael Brooks | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 7,415 | 39,300 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Michael Brooks | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 3,400 | 10,842 (0%) | 0% | 0 | Class A Common Stock | |
| Syneos Health Inc - Ordina... | Michael Brooks | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.09 per share. | 18 Jan 2022 | 1,296 | 7,442 (0%) | 0% | 86.1 | 111,573 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Michael Brooks | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.09 per share. | 18 Jan 2022 | 1,114 | 31,885 (0%) | 0% | 86.1 | 95,904 | Class A Common Stock |
| LKQ | Michael T. Brooks | SVP -- CIO | 14 Jan 2022 | 226 | 16,762 (0%) | 0% | 56.6 | 12,783 | Common Stock | |
| Syneos Health Inc - Ordina... | Michael Brooks | See remarks | Sale of securities on an exchange or to another person at price $ 99.00 per share. | 22 Dec 2021 | 93 | 8,831 (0%) | 0% | 99 | 9,207 | Class A Common Stock |
| Syneos Health Inc - Ordina... | Michael Brooks | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.90 per share. | 16 Dec 2021 | 603 | 8,924 (0%) | 0% | 98.9 | 59,637 | Class A Common Stock |
| LKQ | Michael T. Brooks | SVP -- CIO | 01 Sep 2021 | 536 | 16,988 (0%) | 0% | 52.0 | 27,894 | Common Stock | |
| LKQ | Michael T. Brooks | SVP -- CIO | 14 Jul 2021 | 203 | 17,524 (0%) | 0% | 50.7 | 10,289 | Common Stock | |
| Edesa Biotech Inc | Michael Brooks | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2021 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Edesa Biotech Inc | Michael Brooks | President | Purchase of securities on an exchange or from another person at price $ 5.19 per share. | 25 Mar 2021 | 3,500 | 13,241 (0%) | 0% | 5.2 | 18,165 | Common Shares |
| Edesa Biotech Inc | Michael Brooks | President | Purchase of securities on an exchange or from another person at price $ 5.08 per share. | 24 Mar 2021 | 4,500 | 9,741 (0%) | 0% | 5.1 | 22,860 | Common stock |
| LKQ | Michael T. Brooks | SVP -- CIO | 01 Mar 2021 | 716 | 17,727 (0%) | 0% | 40.5 | 28,970 | Common Stock | |
| LKQ | Michael T. Brooks | SVP -- CIO | 18 Feb 2021 | 7,413 | 18,443 (0%) | 0% | 0 | Common Stock | ||
| LKQ | Michael T. Brooks | SVP -- CIO | 18 Feb 2021 | 418 | 11,030 (0%) | 0% | 38.7 | 16,187 | Common Stock | |
| LKQ | Michael T. Brooks | SVP -- CIO | 14 Jan 2021 | 227 | 11,448 (0%) | 0% | 39.3 | 8,927 | Common Stock | |
| Edesa Biotech Inc | Michael Brooks | President | 06 Nov 2020 | 914 | 0 | - | - | Common Share Warrants (Right to Buy) | ||
| Edesa Biotech Inc | Michael Brooks | President | 06 Nov 2020 | 914 | 5,241 (0%) | 0% | 4 | 3,656 | Common Shares | |
| Edesa Biotech Inc | Michael Brooks | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2020 | 50,000 | 50,000 | - | - | Stock option (right to buy) |